photo of

Details

Role Team Leader / Senior Research Fellow
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an...
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.

Top Publications

  • Li, Y, Wang, X, Blau, DM, Caballero, MT, Feikin, DR, Gill, CJ, Madhi, SA, Omer, SB, Simões, EAF, Campbell, H, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. The Lancet 399(10340) : 2047 -2064 2022
    view publication
  • von Mollendorf, C, Ulziibayar, M, Gessner, BD, Do, LAH, Nguyen, CD, Beavon, R, Suuri, B, Luvsantseren, D, Narangerel, D, Jenney, A, et al. Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study. BMC Public Health 21(1) : 1731 2021
    view publication
  • Ha, LA, Tsedenbal, N, von Mollendorf, C, Mungun, T, Bardach, D, Mulholland, K. What was the real cause of the dramatic increase in measles mortality during the 2015/2016 Mongolian Outbreak?. The Journal of Infectious Diseases 224(7) : 1266 -1268 2021
    view publication
  • Chan, J, Mungun, T, Batsaixan, P, Ulziibayar, M, Suuri, B, Otgonbayar, D, Luvsantseren, D, Nguyen, CD, Narangarel, D, Dunne, EM, et al. Direct and indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in Mongolia: an observational study. The Lancet Regional Health - Western Pacific 15: 100231 2021
    view publication
  • von Mollendorf, C, Lim, R, Choummanivong, M, Sychareun, V, Vilivong, K, Lai, JYR, Chan, J, Dunne, EM, Phommachanh, S, Moore, K, et al. 370Measuring pneumococcal conjugate vaccine impact in a low-resource setting with minimal baseline data. International Journal of Epidemiology 50(Supplement_1) : dyab168.687- 2021
    view publication

Page 7 of 17